XML 55 R38.htm IDEA: XBRL DOCUMENT v3.8.0.1
Acquisitions, Sale of Hospira Infusion Systems Net Assets, Collaborative Arrangement and Equity-Method Investments - Sale of Hospira Infusion Systems Net Assets to ICU Medical, Inc. (EH) (Details) - USD ($)
shares in Millions, $ in Millions
 3 Months Ended 9 Months Ended
Feb. 03, 2017
Oct. 01, 2017
Oct. 02, 2016
Oct. 01, 2017
Oct. 02, 2016
 [2]
Jan. 05, 2017
Oct. 06, 2016
Business Acquisition [Line Items]              
Gain (loss) on sale of HIS net assets [1]   $ 12 $ (1,422) $ (52) [2] $ (1,422)    
HIS [Member] | Disposed of by Sale [Member] | ICU Medical [Member]              
Business Acquisition [Line Items]              
Consideration transferred           $ 900 $ 1,000
Number of shares received in disposition 3.2            
Value of shares received from disposition $ 428            
Promissory note 75            
Cash received from disposition 200            
Contingent consideration $ 225            
Ownership percentage   16.00%   16.00%      
Minimum share transfer restriction term 18 months            
Term of promissory note 3 years            
Gain (loss) on sale of HIS net assets   $ 12   $ (52)      
Administrative service period 24 months            
Maximum manufacturing service period 5 years            
London Interbank Offered Rate (LIBOR) [Member] | HIS [Member] | Disposed of by Sale [Member] | ICU Medical [Member]              
Business Acquisition [Line Items]              
Interest rate of promissory note in year one 2.25%            
Interest rate of promissory note in year two 2.50%            
Interest rate of promissory note in year three 2.50%            
[1] In the third quarter and first nine months of 2017, represents adjustments to amounts previously recorded to write down the HIS net assets to fair value less costs to sell related to the sale of HIS net assets to ICU Medical. In the third quarter and first nine months of 2016, represents a charge related to the write-down of the HIS net assets to fair value less estimated costs to sell.
[2] Amounts may not add due to rounding.